查找临床试验
已按「脊髓性肌萎缩症」检索，对应国际通用词 spinal muscular atrophy
共找到 67 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:19，每 5 分钟自动同步Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
United States
年龄 不限 – 不限
Sanford Health
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
United States
年龄 5 Years – 20 Years
St. Jude Children's Research Hospital
A Registry Based Randomized-Controlled Trial of an Upper Limb Exergaming Intervention for Children and Adolescents With Spinal Muscular Atrophy
Canada
年龄 8 Years – 18 Years
Maryam Oskoui, MD, MSc, FRCPC, FAAN
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
United States、Puerto Rico
年龄 18 Years – 不限
ORIC Pharmaceuticals
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
United States、Belgium、France、Italy、Netherlands 等 7 国
年龄 不限 – 2 Years
Scholar Rock, Inc.
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
United States、China
年龄 15 Years – 60 Years
Biogen
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
United States、France、Germany、Italy、Poland 等 7 国
年龄 3 Years – 不限
Biogen
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
United States
年龄 18 Years – 80 Years
Johns Hopkins University
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
United States
年龄 6 Years – 不限
University of Florida
Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis
France
年龄 18 Years – 不限
University Hospital, Strasbourg, France
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
France
年龄 6 Years – 不限
Centre Hospitalier Universitaire de Saint Etienne
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
United States、Australia、Canada、United Kingdom
年龄 5 Years – 17 Years
argenx